AAB
EW icon

ABN AMRO Bank’s Edwards Lifesciences EW Stock Holding History

ABN AMRO Bank’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$83.6M Buy
924,314
+525,889
+132% +$44.1M 1.08% 30
2026
Q1 		$32.3M Buy
398,425
+220,969
+125% +$18.2M 0.35% 50
2025
Q4 		$15.1M Sell
177,456
-2,146
-1% -$176K 0.14% 82
2025
Q3 		$13.9M Buy
179,602
+1,895
+1% +$148K 0.14% 80
2025
Q2 		$14M Buy
+177,707
New +$13.3M 0.18% 61
2025
Q1 		– Sell
-175,220
Closed -$12.8M – 164
2024
Q4 		$12.8M Buy
175,220
+2,017
+1% +$141K 0.17% 60
2024
Q3 		$11.3M Sell
173,203
-374
-0.2% -$27.2K 0.16% 66
2024
Q2 		$16.2M Sell
173,577
-2,106
-1% -$186K 0.24% 53
2024
Q1 		$16.8M Buy
175,683
+6,229
+4% +$523K 0.25% 52
2023
Q4 		$13M Buy
169,454
+30,849
+22% +$2.15M 0.21% 56
2023
Q3 		$9.6M Buy
138,605
+3,067
+2% +$246K 0.17% 60
2023
Q2 		$12.9M Sell
135,538
-5,338
-4% -$464K 0.26% 41
2023
Q1 		$11.7M Buy
+140,876
New +$11.1M 0.26% 39

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

ABN AMRO Bank's EW Position: Q2 2026 in Review

ABN AMRO Bank increased its Edwards Lifesciences (EW) stake by 132% in Q2 2026, buying an estimated $44.1M and bringing the position to 924,314 shares worth $83.6M. The position accounts for 1.08% of the portfolio, ranked #30.

ABN AMRO Bank first reported a position in EW in Q1 2023 and has held it in 13 quarters since. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • ABN AMRO Bank held 924,314 shares of Edwards Lifesciences worth $83.6M as of Q2 2026.
  • ABN AMRO Bank bought 525,889 Edwards Lifesciences shares in Q2 2026, an estimated $44.1M.
  • Edwards Lifesciences made up 1.08% of ABN AMRO Bank's portfolio in Q2 2026, its #30 holding.
  • ABN AMRO Bank first reported a position in Edwards Lifesciences in Q1 2023 and has held it in 13 quarters since.
  • 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on ABN AMRO Bank's 13F filing for Q2 2026, filed 6 Aug 2026.